Producing high-competent oocytes during the in vitro maturation (IVM) is considered a key
step for the success of the in vitro production (IVP) of embryos. One of the known disruptors …

Reproductive aging is characterized by a decline in oocyte quantity and quality, which is
directly associated with a decline in reproductive potential, as well as poorer reproductive …

Female reproductive capacity declines dramatically in the fourth decade of life as a result of
an age‐related decrease in oocyte quality and quantity. The primary causes of reproductive …

Background Management of women with reduced ovarian reserve or poor ovarian response
(POR) to stimulation is one of the major challenges in reproductive medicine. The primary …

Postovulatory aging is known to compromise the oocyte quality as well as subsequent
embryo development in many different animal models, and becomes one of the most …

Antimüllerian hormone is the most informative serum marker of ovarian reserve currently
available and should be considered an important part of any contemporary reproductive …

Cyclophosphamide (CTX) has been broadly used in the clinic for the treatment of
autoimmune disorders and ovarian cancer. The process of chemotherapy has significant …

In vitro fertilization (IVF) is expensive, time consuming, and the most successful treatment of
fertility; however, in general the cumulative chance of having a live birth with the treatment is …

Acquiring oocyte competence requires optimal mitochondrial function and adequate ATP
levels. In this context, CoQ10 supplementation may improve human oocyte quality and …

With advancing age, women experience irreversible deterioration in the quality of their
oocytes, resulting in reduced fertility. To gain a deeper understanding of the influence of …